PANTHERYX, INC.

Profile

Company Names

PANTHERYX, INC.

Addresses

4845 PEARL EAST CIRCLE, SUITE 101, BOULDER, CO 80301

2235 SOUTH CENTRAL AVENUE, SUITE 325, PHOENIX, AZ 85004

5480 VALMONT ROAD, SUITE 325, BOULDER, CO 80301

5541 CENTRAL AVENUE, SUITE 270, BOULDER, CO 80301

Phone Numbers

3039516883
6023538800
(303) 951-6883
(303) 502-4721

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

COLORADO

Total Amount Raised:

$95,727,423.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2023-10-02 
$52,289,052.00 
$60,000,000.00 
$7,710,948.00 
Equity 
6
2021-04-19 
$9,437,369.00 
$11,895,991.00 
$2,458,622.00 
Equity 
5
2018-07-03 
$10,711,756.00 
$14,999,996.00 
$4,288,240.00 
Equity 
4
2017-09-25 
$8,861,523.00 
$13,000,009.00 
$4,138,486.00 
Equity 
3
2013-04-12 
$9,260,818.00 
$10,000,000.00 
$739,182.00 
Equity 
2
2012-02-14 
$3,541,100.00 
$4,000,000.00 
$458,900.00 
Equity 
1
2010-12-30 
$1,625,805.00 
$1,625,805.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
BRAMAN 
EXECUTIVE OFFICER, DIRECTOR
MARK 
A. 
BRAMAN 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
J. 
COOK 
DIRECTOR
THOMAS 
 
FEELEY 
EXECUTIVE OFFICER
STUART 
HARRIS 
DIRECTOR
JAMES 
T. 
HAU 
EXECUTIVE OFFICER
SCOTT 
A. 
HYMAN 
EXECUTIVE OFFICER
HOLGER 
 
LIEPMANN 
DIRECTOR
CHRIS 
 
LINDSAY 
EXECUTIVE OFFICER
MEHMET 
 
OZ 
DIRECTOR
WES 
 
PARRIS 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
 
SCHULTZ 
EXECUTIVE OFFICER
RAJIV 
 
SHAH 
DIRECTOR
GEORGE 
 
STAGNITTI 
EXECUTIVE OFFICER
BIMLA 
 
STARZL 
EXECUTIVE OFFICER
TIM 
 
STARZL 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TIMOTHY 
 
STARZL 
EXECUTIVE OFFICER, DIRECTOR
GARY 
WES 
THOMAS 
EXECUTIVE OFFICER
FEELEY 
 
TOM 
EXECUTIVE OFFICER
PETER 
J. 
VITULLI 
DIRECTOR
THOMAS 
 
WASHING 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE
NONE
NONE
N/A
NONE